Download to read offline
PPTX, PDF53 views
Transforming the Management of Inflammatory Bowel Disease: A Closer Look at the Role of JAK Inhibitors and the Patient’s Perspective in Achieving Therapeutic Goals.
Chair, David T. Rubin, MD, Jessica R. Allegretti, MD, MPH, and Stephen B. Hanauer, MD, discuss inflammatory bowel disease in this CME activity titled "Transforming the Management of Inflammatory Bowel Disease: A Closer Look at the Role of JAK Inhibitors and the Patient’s Perspective in Achieving Therapeutic Goals." For the full presentation, downloadable Practice Aids, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/36k0BCJ. CME credit will be available until March 2, 2021.
Related topics:
